awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39294074-341EC355-58D8-453A-8B46-E48CBC2582F1
Q39294074-341EC355-58D8-453A-8B46-E48CBC2582F1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39294074-341EC355-58D8-453A-8B46-E48CBC2582F1
Reversal of multidrug resistance by gefitinib via RAF1/ERK pathway in pancreatic cancer cell line.
P2860
Q39294074-341EC355-58D8-453A-8B46-E48CBC2582F1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39294074-341EC355-58D8-453A-8B46-E48CBC2582F1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e906064fda18163c3c88bbfa6ba3470d910c7620
P2860
Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 2.